291
Views
0
CrossRef citations to date
0
Altmetric
Articles

Subjectivity as “evidence”: an exploration of medication adherence in the treatment of schizophrenia using in-depth interviews

References

  • Beck, E., Cavelti, M., Kvrgic, S., Kleim, B., & Vauth, R. (2011). Are we addressing the ‘right stuff’ to enhance adherence in schizophrenia? understanding the role of insight and attitudes towards medication. Schizophrenia Research, 132(1), 42–49. doi:10.1016/j.schres.2011.07.019
  • Bond, G. R., & Drake, R. E. (2015). The critical ingredients of assertive community treatment. World Psychiatry, 14(2), 240–242. doi:10.1002/wps.v14.2
  • Dassa, D., Boyer, L., Benoit, M., Bourcet, S., Raymondet, P., & Bottai, T. (2010). Factors associated with medication non-adherence in patients suffering from schizophrenia: A cross-sectional study in a universal coverage health-care system. Australian and New Zealand Journal of Psychiatry, 44(10), 921–928. doi:10.3109/00048674.2010.493503
  • Foucault, M. (1965). Madness and civilization: A history of insanity in the age of reason. New York: Pantheon Books.
  • Gomory, T. (2013). The limits of evidence-based medicine and its application to mental health evidence-based practice (part two): Assertive community treatment assertively reviewed. Ethical Human Psychology and Psychiatry, 15(2), 73–86. doi:10.1891/1559-4343.15.2.73
  • Hesse-Biber, S., & Leavy, P. (2011). The practice of qualitative research (2nd ed.). Thousand Oaks, CA: Sage Publications.
  • Jenkins, J. H., Strauss, M. E., Carpenter, E. A., Miller, D., Floersch, J., & Sajatovic, M. (2005). Subjective experience of recovery from schizophrenia-related disorders and atypical antipsychotics. International Journal of Social Psychiatry, 51(3), 211–227. doi:10.1177/0020764005056986
  • Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., & Dixon, L. B.; Schizophrenia Patient Outcomes Research Team (PORT). (2010). The schizophrenia patient outcomes research team (PORT): Updated treatment recommendations 2009. Schizophrenia Bulletin, 36(1), 94–103. doi:10.1093/schbul/sbp130
  • Lally, J., & MacCabe, J. H. (2015). Antipsychotic medication in schizophrenia: A review. British Medical Bulletin, 114(1), 169–179. doi:10.1093/bmb/ldv017
  • Mohr, W. K. (1999). Deconstructing the language of psychiatric hospitalization. Journal of Advanced Nursing, 29(5), 1052–1059. doi:10.1046/j.1365-2648.1999.00997.x
  • Morris, L. S., & Schulz, R. M. (1993). Medication compliance: The patient’s perspective. Journal of Clinical and Pharmacy and Therapeutics, 15, 593–606.
  • Morse, G., & McKasson, M. (2005). Assertive Community Treatment. In R. Drake, M. Merren, & D. Lynde (Eds.), Evidence-based mental health practice. New York, NY: W.W. Norton.
  • Reger, J. (2001). Emotions, objectivity and voice: An analysis of a “failed” participant observation. Women’s Studies International Forum, 24(5), 605–615. doi:10.1016/S0277-5395(01)00190-X
  • Rofail, D., Heelis, R., & Gournay, K. (2009). Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication. Clinical Therapeutics, 31(1), 1488–1496. doi:10.1016/j.clinthera.2009.07.001
  • Scheyett, A. (2006). Silence and surveillance: Mental illness, evidence-based practice, and a Foucaultian lens. Journal of Progressive Human Services, 17(1), 71–92. doi:10.1300/J059v17n01_05
  • Velligan, D., Sajatovic, M., Valenstein, M., Riley, W. T., Safren, S., Lewis-Fernandez, R., … Jamison, J. (2010). Methodological challenges in psychiatric treatment adherence research. Clinical Schizophrenia & Related Psychoses, 4(1), 74–91. doi:10.3371/CSRP.4.1.6
  • Williamson, T. (2002). Ethics of assertive outreach (assertive community treatment teams). Current Opinion in Psychiatry, 15(5), 543–547. doi:10.1097/00001504-200209000-00013
  • Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159(10), 1653–1664. doi:10.1176/appi.ajp.159.10.1653

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.